Researchers solid doubt over advantages of recent Alzheimer’s remedies
Eli Lilly and Biogen may now not right away be reached for remark. Those medication have additionally divided regulators. The U.S. Meals and Drug Management authorized lecanemab closing 12 months and donanemab
